Cooley advised Zai Lab on the deal. Zai Lab, a research-based commercial-stage biopharmaceutical company, announced its strategic partnership and exclusive worldwide license agreement with MediLink Therapeutics, as...
Zai Lab’s License Agreement with MediLink Therapeutics
Zai Lab Limited’s Strategic Collaboration and License Agreement with MacroGenics
Goodwin Procter LLP advised Zai Lab Limited on the deal. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its broad strategic collaboration and license agreement with MacroGenics...
Zai Lab’s $857.5 Million Shares Offering
Davis Polk advised Zai Lab Limited in the deal, while Simpson Thacher represented the underwriters. Zai Lab Limited executed its offering of 5,492,400 American depositary shares,...